Miller Anestesia

830 / 2894

tive complications after high-risk surgery. Chest
120:1147–1151, 2001.
14. Katz I, Stradling J, Slutsjy AS, et al: Do patients with
obstructive sleep apnea have thick necks? Am Rev
Respir Dis 141:1228–1231, 1990.
15. Poldermans D, Boersma E, Bax JJ, et al: The effect
of bisoprolol on perioperative mortality and myo-
cardial infarction in high-risk patients undergoing
vascular surgery. N Engl J Med 341:1789–1794,
1999.
16. Fleisher LA, Beckman JA, Brown KA, et al: ACC/
AHA 2006 guideline update on perioperative car-
diovascular evaluation for noncardiac surgery:
Focused update on perioperative beta-blocker
therapy: A report of the American College of Car-
diology/American Heart Association Task Force on
Practice Guidelines. Circulation 113:2662–2674,
2006.
17. Feringa HH, Bax JJ, Boersma E, et al: High-dose
beta-blockers and tight heart rate control reduce
myocardial ischemia and troponin T release in vas-
cular surgery patients. Circulation 114(1
Suppl)I344–I349, 2006.
18. Howell SJ, Sear JW, Foex P: Hypertension, hyperten-
sive heart disease and perioperative cardiac risk. Br
J Anaesth 92:570–583, 2004.
19. Furberg CD, Psaty BM, Pahor M, et al: Clinical
implications of recent findings from the Antihyper-
tensive and Lipid-Lowering Treatment To Prevent
Heart Attack Trial (ALLHAT) and other studies of
hypertension. Ann Intern Med 135:1074–1078,
2001.
20. Lee TH, Marcantonio ER, Mangione CM, et al:
Derivation and prospective validation of a simple
index for prediction of cardiac risk of major non-
cardiac surgery. Circulation 100:1043–1049, 1999.
21. Tait AR, Parr HG, Tremper KK: Evaluation of the
efficacy of routine preoperative electrocardiograms.
J Cardiothorac Vasc Anesth 11:752–755, 1997.
22. Liu LL, Dzankic S, Leung JM: Preoperative electro-
cardiogram abnormalities do not predict postope-
rative cardiac complications in geriatric surgical
patients. J Am Geriatr Soc 50:1186–1191, 2002.
23. Wei L, MacDonald TM, Walker BR: Taking gluco-
corticoids by prescription is associated with subse-
quent cardiovascular disease. Ann Intern Med
141:764–770, 2004.
24. Asanuma Y, Oeser A, Shintani AK, et al: Premature
coronary-artery atherosclerosis in systemic lupus
erythematosus. N Engl J Med 349:2407–2415,
2003.
25. McFalls EO, Ward HB, Mortiz TE, et al: Coronary-
artery revascularization before elective major vas-
cular surgery. N Engl J Med 351:2795–2804, 2004.
26. Breen P,Wee JW,Pomposelli F,et al: Timing of high-
risk vascular surgery following coronary artery
bypass surgery: A 10-year experience from an aca-
demic medical centre. Anaesthesia 59:422–427,
2004.
27. Grines CL, Bonow RO, Casey DE, et al: Prevention
of premature discontinuation of dual antiplatelet
therapy in patients with coronary artery stents. J
Am Coll Cardiol 49:734–739, 2007.
28. Grayburn PA, Hillis LD: Cardiac events in patients
undergoing noncardiac surgery: Shifting the para-
digm from noninvasive risk stratification to therapy.
Ann Intern Med 138:506–511, 2003.
29. Topol EJ, Nissen SE: Our preoccupation with coro-
nary luminology: The dissociation between clinical
and angiographic findings in ischemic heart disease.
Circulation 92:2333–2342, 1995.
30. Singh AK, Szczech L, Tang KL, et al: Correction of
anemia with epoetin alfa in chronic kidney disease.
N Engl J Med 355:2085–2098, 2006.
31. Wu W-C, Schifftner TI, Henderson WG, et al: Preo-
perative hematocrit levels and postoperative outco-
mes in older patients undergoing noncardiac
surgery. JAMA 297:2481–2488, 2007.
32. Thom T, Haase N, RosamondW, et al: Heart disease
and stroke statistics—2006 update: A report from
the American Heart Association Statistics Commit-
tee and Stroke Statistics Subcommittee. Circulation
113:e85–e151, 2006.
33. Mahler DA, Harver A, Lentine T, et al: Descriptors
of breathlessness in cardiorespiratory diseases. Am
J Respir Crit Care Med 154:1357–1363, 1996.
34. Criteria Committee of the NewYork Heart Associa-
tion: Nomenclature and Criteria for Diagnosis of
Disease of the Heart and Great Vessels, 9th ed.
Boston, Little, Brown, 1994.
35. Januzzi JL Jr, Camargo CA,Anwaruddin S, et al: The
N-terminal Pro-BNP investigation of Dyspnea in
the Emergency Department (PRIDE) study. Am J
Cardiol 95:948–954, 2005.
36. Maisel AS,Krishnaswamy P,Nowak RM,et al: Rapid
measurement of B-type natriuretic peptide in the
emergency diagnosis of heart failure. N Engl J Med
347:161–167, 2002.
37. Dernellis J, Panaretou M: Assessment of cardiac risk
before non-cardiac surgery: Brain natriuretic
peptide in 1590 patients. Heart 92:1645–1650,
2006.
38. Feringa HH, Schouten O, Dunkelgrun M, et al:
Plasma N-terminal pro–B-type natriuretic peptide
as long-term prognostic marker after major vascu-
lar surgery. Heart 93:226–231, 2007.
39. Carabello BA, Crawford FA: Valvular heart disease.
N Engl J Med 337:32–41, 1997.
40. Bonow RO, Carabello B, de Leon AC Jr, et al: ACC/
AHA guidelines for the management of patients
with valvular heart disease. J Am Coll Cardiol
32:1486–1588, 1998, Available at
Accessed July 5, 2007.
41. Otto CM, Lind BK, Kitzman DW, et al: Association
of aortic-valve sclerosis with cardiovascular morta-
lity and morbidity in the elderly. N Engl J Med
341:142–147, 1999.
42. Aronow WS, Ahn C, Shirani J, et al: Comparison of
frequency of new coronary events in older subjects
with and without valvular aortic sclerosis. Am J
Cardiol 83:599–600, 1999.
43. WilsonW, Taubert K, Gewitz M, et al: Prevention of
infective endocarditis. Guidelines from the Ameri-
can Heart Association. Circulation 116:1736–1754,
2007.
44. Desjardins VA, Enriquez-Sarano M, Tajik AJ, et al:
Intensity of murmurs correlates with severity of
valvular regurgitation. Am J Med 100:149–156,
1996.
45. Gregoratos G, Abrams J, Epstein AE, et al: ACC/
AHA/NASPE 2002 guideline update for implanta-
tion of cardiac pacemakers and antiarrhythmia
devices: Summary article.A report of the American
College of Cardiology/American Heart Association
Task Force on Practice Guidelines (ACC/AHA/
NASPE Committee to Update the 1998 Pacemaker
Guidelines). Circulation 106:2145–2161, 2002.
46. Eriksson P, Wilhelmsen L, Rosengren A: Bundle-
branch block in middle-aged men: Risk of compli-
cations and death over 28 years. The Primary
Prevention Study in Goteborg, Sweden. Eur Heart J
26:2300–2306, 2005.
47. Dhingra R, Pencina MJ, Wang TJ, et al: Electrocar-
diographic QRS duration and the risk of congestive
heart failure: The Framingham Heart Study. Hyper-
tension 47:861–867, 2006.
48. Landesberg G, Einav S, Christopherson R, et al:
Perioperative ischemia and cardiac complications
in major vascular surgery: Importance of the preo-
perative twelve-lead electrocardiogram. J Vasc Surg
26:570–578, 1997.
49. National Asthma Education and Prevention
Program: Expert Panel Report: Guidelines for the
diagnosis and management of asthma update on
selected topics—2002. J Allergy Clin Immunol
110:S141–S219, 2002.
50. Wong DH,Weber EC, Schell MJ, et al: Factors asso-
ciated with postoperative pulmonary complications
in patients with severe chronic obstructive pulmo-
nary disease. Anesth Analg 80:276–284, 1995.
51. McAlister FA, Bertsch K, Man J, et al: Incidence of
and risk factors for pulmonary complications after
nonthoracic surgery. Am J Respir Crit Care Med
171:514–517, 2005.
52. Arozullah AM, Daley J, Henderson WG, et al: Mul-
tifactorial risk index for predicting postoperative
respiratory failure in men after major noncardiac
surgery. Ann Surg 232:242–253, 2000.
53. Warner DO,Warner MA, Barnes RD, et al: Periope-
rative respiratory complications in patients with
asthma. Anesthesiology 85:460–467, 1996.
54. De Nino LA, Lawrence VA, Averyt EC, et al: Preo-
perative spirometry and laparotomy: Blowing away
dollars. Chest 111:1536–1541, 1997.
55. Smetana GW, Lawrence VA, Cornell JE, American
College of Physicians: Preoperative pulmonary risk
stratification for noncardiothoracic surgery. Ann
Intern Med 144:581–595, 2006.
56. Ballantyne JC,Carr DB,deFerranti S,et al: The com-
parative effects of postoperative analgesic therapies
on pulmonary outcome: Cumulative meta-analyses
of randomized, controlled trials. Anesth Analg
86:598–612, 1998.
57. Ramakrishna G, Sprung J, Ravi BS, et al: Impact of
pulmonary hypertension on the outcomes of non-
cardiac surgery: Predictors of perioperative morbi-
dity and mortality.J Am Coll Cardiol 45:1691–1699,
2005.
58. Blaise G, Langleben D, Hurbert B: Pulmonary arte-
rial hypertension: Pathophysiology and anesthetic
approach. Anesthesiology 99:1415–1432, 2003.
59. McGoon M, Gutterman D, Steen V, et al: Screening,
early detection, and diagnosis of pulmonary artery
hypertension. Chest 126(Suppl)14–34, 2004.
60. Bradley TD, Floras JS: Sleep apnea and heart failure:
Part I. Obstructive sleep apnea. Circulation
107:1671–1678, 2003.
61. Myles PS, Iacono GA, Hunt JO, et al: Risk of respira-
tory complications and wound infection in patients
undergoing ambulatory surgery: Smokers versus
nonsmokers. Anesthesiology 97:842–847, 2002.
62. Woehlck HJ, Connolly LA, Cinquegrani MP, et al:
Acute smoking increases ST depression in humans
during general anesthesia. Anesth Analg 89:856–
860, 1999.
63. A clinical practice guideline for treating tobacco use
and dependence. JAMA 283:3244–3254, 2000.
64. Warner DO: Helping surgical patients quit smoking:
Why, when and how? Anesth Analg 101:481–487,
2005.
65. Haffner SM, Lehto S, Ronnemaa T, et al: Mortality
from coronary heart disease in subjects with type 2
diabetes and in nondiabetic subjects with and
without prior myocardial infarction. N Engl J Med
339:229–234, 1998.
66. Garber AJ,Moghissi ES,Bransome ED Jr,et al:Ame-
rican College of Endocrinology position statement
on inpatient diabetes and metabolic control.Endocr
Pract 10:77–82, 2004.
67. Dickstein G,Shechner C,NicholsonWE,et al:Adre-
nocorticotropin stimulation test: Effects of basal
cortisol level, time of day, and suggested new sensi-
tive low dose test. J Clin Endocrinol Metab 72:773–
778, 1991.
68. Brandi ML, Gagel RF, Angeli A, et al: Guidelines for
diagnosis and therapy of MEN type 1 and type 2. J
Clin Endocrinol Metab 86:5658–5671, 2001.
69. Kinney MAO, Narr BJ, Warner MA: Perioperative
management of pheochromocytoma. J Cardiotho-
rac Vasc Anesth 16:359–369, 2002.
70. Straumann E, Meyer B, Misteli M, et al: Aortic and
mitral valve disease in patients with end stage renal
failure on long-term haemodialysis. Br Heart J
67:236–239, 1992.
71. Umana E,AhmedW,Alpert MA: Valvular and peri-
valvular abnormalities in end-stage renal disease.
Am J Med Sci 325:237–242, 2003.
72. Hirakata RG, Alphorns N, Joshi RM, et al: Palliative
surgery in malignant obstructive jaundice: Prog-
nostic indicators of early mortality. J R Coll Surg
Edinb 42:238–243, 1997.
73. Fogarty BJ, Parks RW, Rowlands BJ, et al: Renal dys-
function in obstructive jaundice. Br J Surg 82:877–
884, 1995.
74. Befeler AS, Palmer DE, Hoffman M, et al: The safety
of intra-abdominal surgery in patients with cirrho-
sis: Model for End-Stage Liver Disease score is
superior to Child-Turcotte-Pugh classification in
predicting outcome. Arch Surg 140:650–654, 2005.
830 Control de la anestesia III